A recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis — Lou Gehrig’s disease, a uniformly fatal neurodegenerative disorder, new stem cell research has shown. The researchers are now designing an initial clinical trial testing the safety of the treatment in ALS patients.